caa a22 4500 605490449 CHVBK 20210128100505.0 cr unu---uuuuu 210128e20150201xx s 000 0 eng 10.1007/s10147-014-0683-5 doi (NATIONALLICENCE)springer-10.1007/s10147-014-0683-5 A statistical study on malignant melanoma over the past 12years in Fukui University Hospital [Elektronische Daten] [Masato Yasuta, Suguru Sato, Sachio Kouraba, Shiro Iino, Takahiro Kiyohara] Background: The survival rate of patients with malignant melanoma is still low, and there is no established chemotherapeutic method. With the appearance of molecular targeted drugs, improvement in the survival rate can be expected. However, at present, malignant melanoma remains a disease associated with one of the poorest prognoses. Materials and methods: We analyzed a total of 51 cases of malignant melanoma who were treated at the Department of Dermatology, University of Fukui from September 2001 to May 2013. Results: The survival rate was significantly lower in patients aged ≥65years. The 5-year survival rate was 100% for Stage 0/I, 79.59% for Stage II, and 52% for Stage III. The incidence of lymph node metastasis was highest in nodular melanoma, and zero in lentigo maligna melanoma. There was a significantly high risk of lymph node metastasis in the presence of ulceration. There was no association between incisional biopsy and lymph node metastasis. Conclusions: Although the data were obtained in only one institution and the number of cases was limited in this study, the results are close to previous international data. Japan Society of Clinical Oncology, 2014 Malignant melanoma nationallicence Statistical study nationallicence Incisional biopsy nationallicence In-transit metastasis nationallicence Survival rate nationallicence Yasuta Masato Division of Plastic and Reconstructive Surgery, Department of Dermatology, School of Medicine, University of Fukui, 23-3 Matsuoka-shimoaizuki, 910-1193, Fukui, Japan aut Sato Suguru Division of Plastic and Reconstructive Surgery, Department of Dermatology, School of Medicine, University of Fukui, 23-3 Matsuoka-shimoaizuki, 910-1193, Fukui, Japan aut Kouraba Sachio Sapporo Wound-Care and Anti-Aging Laboratory, Sapporo, Japan aut Iino Shiro Department of Dermatology, University of Fukui, Fukui, Japan aut Kiyohara Takahiro Department of Dermatology, University of Fukui, Fukui, Japan aut International Journal of Clinical Oncology Springer Japan 20/1(2015-02-01), 182-187 1341-9625 20:1<182 2015 20 10147 https://doi.org/10.1007/s10147-014-0683-5 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10147-014-0683-5 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Yasuta Masato Division of Plastic and Reconstructive Surgery, Department of Dermatology, School of Medicine, University of Fukui, 23-3 Matsuoka-shimoaizuki, 910-1193, Fukui, Japan aut NATIONALLICENCE 700 1- Sato Suguru Division of Plastic and Reconstructive Surgery, Department of Dermatology, School of Medicine, University of Fukui, 23-3 Matsuoka-shimoaizuki, 910-1193, Fukui, Japan aut NATIONALLICENCE 700 1- Kouraba Sachio Sapporo Wound-Care and Anti-Aging Laboratory, Sapporo, Japan aut NATIONALLICENCE 700 1- Iino Shiro Department of Dermatology, University of Fukui, Fukui, Japan aut NATIONALLICENCE 700 1- Kiyohara Takahiro Department of Dermatology, University of Fukui, Fukui, Japan aut NATIONALLICENCE 773 0- International Journal of Clinical Oncology Springer Japan 20/1(2015-02-01), 182-187 1341-9625 20:1<182 2015 20 10147